itraconazole and Long QT Syndrome
itraconazole has been researched along with Long QT Syndrome in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Bentley, D; Derks, M; Diack, C; Jaminion, F; Wandel, C; Wang, K | 1 |
Agresta, S; Bowden, C; Dai, D; Fan, B; Hickman, D; Liu, G; Liu, H; Nabhan, S; Prakash, C; Vutikullird, A; Yang, H; Zacher, J | 1 |
Nieber, K; Rufke, C | 1 |
Cha, IJ; Jung, HJ; Kim, KA; Park, JY; Shim, JC; Shin, JG; Shon, JH; Yoon, YR | 1 |
Chroust, K; Floriánová, A; Kadlecová, J; Papousek, I; Sisáková, M; Spinar, J; Toman, O | 1 |
Froger, CL; Romkes, JH; Westerhof, PW; Wever, EF | 1 |
Reviews
1 review(s) available for itraconazole and Long QT Syndrome
Article | Year |
---|---|
[Long QT interval. Interaction of terfenadine and itraconazole].
Topics: Antifungal Agents; Histamine H1 Antagonists; Humans; Itraconazole; Long QT Syndrome; Onychomycosis; Rhinitis, Allergic, Seasonal; Terfenadine | 2006 |
Trials
3 trial(s) available for itraconazole and Long QT Syndrome
Article | Year |
---|---|
PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration.
Topics: Adult; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Electrocardiography; Female; GABA-A Receptor Antagonists; Healthy Volunteers; Heart Rate; Humans; Itraconazole; Long QT Syndrome; Male; Middle Aged; Models, Biological; Single-Cell Analysis; Young Adult | 2020 |
Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Area Under Curve; Asian People; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Food-Drug Interactions; Glycine; Healthy Volunteers; Humans; Itraconazole; Leukemia, Myeloid, Acute; Long QT Syndrome; Male; Middle Aged; Pyridines | 2019 |
Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.
Topics: Adult; Akathisia, Drug-Induced; Antifungal Agents; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Haloperidol; Humans; Itraconazole; Korea; Liver; Long QT Syndrome; Male; Polymorphism, Genetic | 2006 |
Other Studies
2 other study(ies) available for itraconazole and Long QT Syndrome
Article | Year |
---|---|
[Extension of QT interval as a consequence of risk factor accumulation--case study].
Topics: Adult; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Drug Interactions; Female; Histamine H1 Antagonists; Humans; Itraconazole; Long QT Syndrome; Terfenadine; Torsades de Pointes; Ventricular Dysfunction, Left | 2006 |
[Syncopes during simultaneous use of terfenadine and itraconazole].
Topics: Adult; Anti-Allergic Agents; Antifungal Agents; Cardiotonic Agents; Female; Humans; Isoproterenol; Itraconazole; Long QT Syndrome; Mycoses; Rhinitis, Allergic, Seasonal; Syncope; Terfenadine | 1997 |